(Q4008670)

CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N

1 reference

stated in

PubChem

PubChem CID

70689318

language of work or name

Vapreotide (English)

21 September 2016

CC(C)[C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@@H](CC6=CNC7=CC=CC=C76)C(=O)N

1 reference

language of work or name

English

title

Vapreotide (English)

retrieved

21 September 2016

World Health Organisation international non-proprietary name

Vapreotide (English)

1 reference

language of work or name

Vapreotide (English)

19 January 2016

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

C051458

retrieved

15 March 2018

Identifiers

InChI

InChI=1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)/t40-,43+,44+,45-,46+,47+,48+,49+/m1/s1

1 reference

based on heuristic

inferred from SMILES

InChIKey

SWXOGPJRIDTIRL-KTJGOPLGSA-N

1 reference

language of work or name

Vapreotide (English)

21 September 2016

1 reference

language of work or name

Vapreotide (English)

17 November 2015

1 reference

language of work or name

English

title

(4R,7S,10S,13S,16R,19R)-10-(4-Aminobutyl)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxo-2-propanyl]-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1 (English)

21 September 2016

2 references

language of work or name

English

title